SLC25A5 and neoplasm: One week after the final intratumoral injection of respective ANT2 shRNA-1, shRNA-2 and shRNA-3 (day 32), increased apoptotic cell death was detected by Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling assay (Figure 6b) and the suppression of ANT2 was detected by RT-PCR (data not shown) from the tumor tissues obtained from ANT2 shRNA-treated mice.